Key Dates

Related Announcements

PA-21-151 - NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Issued by

National Eye Institute (NEI)

Purpose

This Notice of Special Interest (NOSI) is to solicit applications to support conferences, symposia, and workshops aimed at supporting the National Eye Institute’s (NEI) Audacious Goals Initiative.

Background

The Audacious Goals Initiative (AGI) for Regenerative Medicine is an effort by the National Eye Institute (NEI) to support science on vision restoration through replacement of retinal cells damaged by disease or injury and to restore their connections to the visual centers of the brain. AGI research specifically targets photoreceptors and retinal ganglion cells. In addition to funding research initiatives, the NEI has organized workshops, seminars, and symposia to support the AGI.

Objectives

The objective of this NOSI is to encourage the research community to organize targeted scientific meetings that would supplement current NEI’s AGI efforts. Topics might include but are not limited to stem cell differentiation, retinal cell and tissue transplantation, conversion of endogenous cell types to photoreceptors and/or retinal ganglion cells, creating a permissive environment for regeneration and reconnection, or other topics relevant to the goals of AGI. We particularly encourage the merging of expertise from multiple disciplines including non-vision related fields. Either in-person or virtual meeting formats will be considered provided they include adequate opportunity for interaction among attendees.

The NEI encourages enhanced participation of junior scientists and trainees.

Application and Submission Information

This notice applies to due dates on or after August 12, 2021 and subsequent receipt dates through May 7, 2024.

Submit applications for this initiative using the following funding opportunity announcement (FOA) or any reissues of this announcement through the expiration date of this notice:

• PA-21-151 - NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the additional considerations:

• For funding consideration under this NOSI, applicants must include “NOT-EY-21-009” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form.

Applications nonresponsive to terms of this NOSI will not be considered for the NOSI initiative.

Inquiries

Scientific/Research Contact(s)

Houmam Araj, PhD
Phone: 301-451-2020
Email: arajh@mail.nih.gov

Peer Review Contact(s)

Brian Hoshaw, PhD
Phone: 301-451-2020
Email: brian.hoshaw@nih.gov

Financial/Grants Management Contact(s)

Karen Robinson-Smith
Phone: 301-451-2020
Email: Karen.Robinson.Smith@nei.nih.gov